RKTO
Rocket One Inc. - Common Stock (RKTO)
$76
About Rocket One Inc. - Common Stock (RKTO)
Rocket One, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in Hoboken, NJ.
Details
Daily high
$0.77
Daily low
$0.72
Price at open
$0.76
52 Week High
$2.45
52 Week Low
$0.49
Market cap
19.1M
Dividend yield
-
Volume
762,125
Avg. volume
654,604
P/E ratio
-.95
Rocket One Inc. - Common Stock News
Details
Daily high
$0.77
Daily low
$0.72
Price at open
$0.76
52 Week High
$2.45
52 Week Low
$0.49
Market cap
19.1M
Dividend yield
-
Volume
762,125
Avg. volume
654,604
P/E ratio
-.95